摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,9-dibenzylcarbonyl-1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane

中文名称
——
中文别名
——
英文名称
3,9-dibenzylcarbonyl-1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane
英文别名
3,9-Dibenzylcarbonyl-1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02.7.04.11.05.10]dodecane;2-phenyl-1-[1,5,7,11-tetrakis(hydroxymethyl)-6,12-bis(4-methoxyphenyl)-9-(2-phenylacetyl)-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecan-3-yl]ethanone
3,9-dibenzylcarbonyl-1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diazapentacyclo[6.4.0.0<sup>2,7</sup>.0<sup>4,11</sup>.0<sup>5,10</sup>]dodecane化学式
CAS
——
化学式
C44H46N2O8
mdl
——
分子量
730.858
InChiKey
BWGFJSDAEQLDOL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    54
  • 可旋转键数:
    12
  • 环数:
    10.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    140
  • 氢给体数:
    4
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    tetramethyl 3,9-dibenzylcarbonyl-6,12-bis(4-methoxyphenyl)-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5,7,11-tetracarboxylate 在 calcium borohydride 作用下, 以 四氢呋喃 为溶剂, 反应 672000.0h, 以90%的产率得到3,9-dibenzylcarbonyl-1,5,7,11-tetrahydroxymethyl-6,12-bis(4-methoxyphenyl)-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane
    参考文献:
    名称:
    Cage DimericN-Acyl- andN-Acyloxy-4-aryl-1,4-dihydropyridines as First Representatives of a Novel Class of HIV-1 Protease Inhibitors
    摘要:
    The synthesis of a series of novel cage dimeric N-acyl and N-acyl-oxy-3-aryl-1,4-dihydropyridines starting either from solid-state synthetic ester dimers or hom monomeric 4-aryl-1,4-dihydropyridines is presented. Their biological evaluation as novel HIV-1 protease inhibitors showed the most active compounds to be 5c and 5i with inhibitory activities of 52% (50 mu M) and 49% (25 mu M), respectively. Within each series of N-acyl- and N-acyloxy derivatives NCOBz and NBoc groups were found to be the best substituents. Although they exhibiting only moderate activities these cage dimers hold promise as a class of novel non-peptidic HIV-1 protease inhibitors.
    DOI:
    10.1002/(sici)1521-4184(199911)332:11<380::aid-ardp380>3.0.co;2-t
点击查看最新优质反应信息

文献信息

  • Cage DimericN-Acyl- andN-Acyloxy-4-aryl-1,4-dihydropyridines as First Representatives of a Novel Class of HIV-1 Protease Inhibitors
    作者:Andreas Hilgeroth、Andreas Billich
    DOI:10.1002/(sici)1521-4184(199911)332:11<380::aid-ardp380>3.0.co;2-t
    日期:1999.11
    The synthesis of a series of novel cage dimeric N-acyl and N-acyl-oxy-3-aryl-1,4-dihydropyridines starting either from solid-state synthetic ester dimers or hom monomeric 4-aryl-1,4-dihydropyridines is presented. Their biological evaluation as novel HIV-1 protease inhibitors showed the most active compounds to be 5c and 5i with inhibitory activities of 52% (50 mu M) and 49% (25 mu M), respectively. Within each series of N-acyl- and N-acyloxy derivatives NCOBz and NBoc groups were found to be the best substituents. Although they exhibiting only moderate activities these cage dimers hold promise as a class of novel non-peptidic HIV-1 protease inhibitors.
查看更多